Diacylglycerol Signaling

More documents

Recommendations

Info

Current Cancer Research For other titles published in this series, go to www.springer.com/series/7892
Page 6: Marcelo G. Kazanietz Editor Protein
Page 10: Acknowledgements The field of PKC a
Page 16: viii Contents 9 PKC and the Control
Page 22: Contributors Antonia Avila-Flores D
Page 26: Contributors Sofia D Merajver Divis
Page 30: Part I Regulation of PKC Isozyme Fu
Page 34: 4 A. Toker to recognize the landmar
Page 38: 6 A. Toker carboxyl-terminal sites,
Page 42: 8 A. Toker Streb, H., Irvine, R. F.
Page 46: 10 A.C. Newton 2.1 Introduction The
Page 50: 12 A.C. Newton Fig. 2.2 Structure o
Page 54:
Fig. 2.3 Schematic illustrating the
Page 58:
16 A.C. Newton protein kinase C bou
Page 62:
18 A.C. Newton degradation, the tot
Page 66:
20 A.C. Newton diacylglycerol, a me
Page 70:
22 A.C. Newton Keranen, L.M., Dutil
Page 74:
Chapter 3 Phorbol Esters and Diacyl
Page 78:
3 Phorbol Esters and Diacylglycerol
Page 82:
Page 86:
Page 90:
Page 94:
Page 98:
Page 102:
Page 106:
Page 110:
Page 114:
Page 118:
Page 122:
Page 126:
Page 130:
Page 134:
56 I. Mérida et al. 4.1 DAG Metabo
Page 138:
58 I. Mérida et al. These enzymes
Page 142:
60 I. Mérida et al. Dysregulation
Page 146:
62 I. Mérida et al. This model con
Page 150:
64 I. Mérida et al. (Yang et al. 2
Page 154:
66 I. Mérida et al. ceramide kinas
Page 158:
68 I. Mérida et al. Different line
Page 162:
70 I. Mérida et al. 4.5 Concluding
Page 166:
72 I. Mérida et al. Cases, S., Sto
Page 170:
74 I. Mérida et al. Jones, D. R.,
Page 174:
76 I. Mérida et al. Pitson, S. M.,
Page 178:
78 I. Mérida et al. Yang, C., Liu,
Page 182:
80 J. Kim and D. Mochly-Rosen desig
Page 186:
82 J. Kim and D. Mochly-Rosen (Moch
Page 190:
84 J. Kim and D. Mochly-Rosen were
Page 194:
86 J. Kim and D. Mochly-Rosen V5 do
Page 198:
88 J. Kim and D. Mochly-Rosen Table
Page 202:
90 J. Kim and D. Mochly-Rosen indic
Page 206:
92 J. Kim and D. Mochly-Rosen an ef
Page 210:
94 J. Kim and D. Mochly-Rosen actio
Page 214:
96 J. Kim and D. Mochly-Rosen isozy
Page 218:
98 J. Kim and D. Mochly-Rosen Emanu
Page 222:
100 J. Kim and D. Mochly-Rosen Kraf
Page 226:
102 J. Kim and D. Mochly-Rosen Saur
Page 230:
Part II PKC Isozymes in the Control
Page 234:
108 G.K. Lønne and C. Larsson Neve
Page 238:
110 G.K. Lønne and C. Larsson resp
Page 242:
112 G.K. Lønne and C. Larsson Refe
Page 246:
114 G.K. Lønne and C. Larsson Kaza
Page 250:
Chapter 7 Regulation and Function o
Page 254:
7 Regulation and Function of Protei
Page 258:
Page 262:
Page 266:
Page 270:
Page 274:
Page 278:
Page 282:
Page 286:
Page 290:
Page 294:
Page 298:
Page 302:
Page 306:
Page 310:
Page 314:
Page 318:
Page 322:
Page 326:
Chapter 8 PKC and Control of the Ce
Page 330:
8 PKC and Control of the Cell Cycle
Page 334:
Page 338:
Page 342:
Page 346:
Page 350:
Page 354:
Page 358:
Page 362:
Page 366:
Page 370:
Page 374:
Page 378:
Page 382:
Page 386:
Page 390:
Page 394:
Chapter 9 PKC and the Control of Ap
Page 398:
9 PKC and the Control of Apoptosis
Page 402:
Page 406:
Page 410:
Page 414:
Page 418:
Page 422:
Page 426:
Page 430:
Page 434:
Page 438:
Page 442:
Page 446:
Page 450:
Page 454:
Page 458:
Page 462:
Chapter 10 Atypical PKCs, NF-kB, an
Page 466:
10 Atypical PKCs, NF-kB, and Inflam
Page 470:
Page 474:
Page 478:
Page 482:
Page 486:
Page 490:
Page 494:
Page 498:
Page 502:
Page 506:
Part III PKC Isozymes in Cancer
Page 510:
248 M.G. Kazanietz to NIH 3T3 cells
Page 514:
250 M.G. Kazanietz Kiley, S. C., Cl
Page 518:
Chapter 12 Protein Kinase C, p53, a
Page 522:
12 Protein Kinase C, p53, and DNA D
Page 526:
Page 530:
Page 534:
Page 538:
Page 542:
Page 546:
268 N.A. Riobo PTCH Patched SMO Smo
Page 550:
270 N.A. Riobo OFF Hh ON N PATCHED
Page 554:
272 N.A. Riobo 13.3 Hedgehog Signal
Page 558:
274 N.A. Riobo the activation of Gl
Page 562:
276 N.A. Riobo vertebrates in a b-c
Page 566:
278 N.A. Riobo numerous colon polyp
Page 570:
280 N.A. Riobo It is remarkable tha
Page 574:
282 N.A. Riobo Some Wnt isoforms, k
Page 578:
284 N.A. Riobo James, R.G., Conrad,
Page 582:
286 N.A. Riobo Rohatgi, R., Milenko
Page 586:
288 Q.J. Wang (Blumberg 1988). DAG
Page 590:
290 Q.J. Wang Gbg PKCh PKD PI4K III
Page 594:
292 Q.J. Wang 2003b). At the mitoch
Page 598:
294 Q.J. Wang tumors and their prop
Page 602:
296 Q.J. Wang regulating integrin r
Page 606:
298 Q.J. Wang 14.6 Concluding Remar
Page 610:
300 Q.J. Wang Harrison, B. C., Kim,
Page 614:
302 Q.J. Wang Storz, P., Doppler, H
Page 618:
Chapter 15 Transgenic Mouse Models
Page 622:
15 Transgenic Mouse Models to Inves
Page 626:
Page 630:
Page 634:
Page 638:
Page 642:
Page 646:
Page 650:
Page 654:
324 M.F. Denning common subtype of
Page 658:
326 M.F. Denning Fig. 16.1 PKC isoz
Page 662:
328 M.F. Denning and CXCR2 ligands
Page 666:
330 M.F. Denning Fig. 16.2 Model of
Page 670:
332 M.F. Denning 16.3 Basal Cell Ca
Page 674:
334 M.F. Denning Fig. 16.3 PKC in m
Page 678:
336 M.F. Denning some benign nevi a
Page 682:
338 M.F. Denning Cataisson, C., Pea
Page 686:
340 M.F. Denning Gilhooly, E. M., M
Page 690:
342 M.F. Denning Nishizuka, Y. (198
Page 694:
344 M.F. Denning Sikkink, S. K., Re
Page 698:
Chapter 17 PKC and Breast Cancer *
Page 702:
17 PKC and Breast Cancer Relative E
Page 706:
17 PKC and Breast Cancer The array
Page 710:
17 PKC and Breast Cancer 17.7 Growt
Page 714:
17 PKC and Breast Cancer showed tha
Page 718:
17 PKC and Breast Cancer de Vente,
Page 722:
17 PKC and Breast Cancer Palmantier
Page 726:
Chapter 18 PKC and Prostate Cancer
Page 730:
18 PKC and Prostate Cancer In Dunni
Page 734:
18 PKC and Prostate Cancer may be c
Page 738:
18 PKC and Prostate Cancer an inhib
Page 742:
18 PKC and Prostate Cancer protein-
Page 746:
18 PKC and Prostate Cancer expressi
Page 750:
18 PKC and Prostate Cancer PKCbII a
Page 754:
18 PKC and Prostate Cancer Gonzalez
Page 758:
18 PKC and Prostate Cancer Sakamoto
Page 762:
Chapter 19 Protein Kinase C and Lun
Page 766:
19 Protein Kinase C and Lung Cancer
Page 770:
Page 774:
Page 778:
Page 782:
Page 786:
Page 790:
Page 794:
Page 798:
Page 802:
Page 806:
Chapter 20 Introduction Patricia S.
Page 810:
20 Introduction The first compound
Page 814:
20 Introduction Tamaoki, T., & Naka
Page 818:
410 A. Basu DNA. Because chemothera
Page 822:
412 A. Basu to doxorubicin was asso
Page 826:
414 A. Basu PKC in vitro (Chambers
Page 830:
416 A. Basu decreasing the levels o
Page 834:
418 A. Basu of cisplatin-sensitive
Page 838:
420 A. Basu 21.3.4 Mechanism of PKC
Page 842:
422 A. Basu In contrast, PKCi but n
Page 846:
424 A. Basu Brodie, C., & Blumberg,
Page 850:
426 A. Basu Higgins, C. F. (1993).
Page 854:
428 A. Basu Pulaski, L., Szemraj, J
Page 858:
Chapter 22 PKCd as a Target for Che
Page 862:
22 PKCd as a Target for Chemotherap
Page 866:
Page 870:
Page 874:
Page 878:
Page 882:
Page 886:
Page 890:
Page 894:
Page 898:
Page 902:
Page 906:
456 V. Justilien and A.P. Fields fa
Page 910:
458 V. Justilien and A.P. Fields By
Page 914:
460 V. Justilien and A.P. Fields In
Page 918:
462 V. Justilien and A.P. Fields en
Page 922:
464 V. Justilien and A.P. Fields A
Page 926:
466 V. Justilien and A.P. Fields sm
Page 930:
468 V. Justilien and A.P. Fields PK
Page 934:
470 V. Justilien and A.P. Fields 23
Page 938:
472 V. Justilien and A.P. Fields in
Page 942:
474 V. Justilien and A.P. Fields pr
Page 946:
476 V. Justilien and A.P. Fields un
Page 950:
478 V. Justilien and A.P. Fields Ad
Page 954:
480 V. Justilien and A.P. Fields Go
Page 958:
482 V. Justilien and A.P. Fields Mu
Page 962:
484 V. Justilien and A.P. Fields Wa
Page 966:
486 Index Apoptotic effectors, 192
Page 970:
488 Index Cell survival (cont.) pro
Page 974:
490 Index Lung cancer (cont.) physi
Page 978:
492 Index Proliferation and cell-cy
Page 982:
494 Index Tumor suppression and pro
show all

Diacylglycerol Signaling

Create successful ePaper yourself

Delete template?

Save as template?